Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	921,876 L.L
N02CC03	ZOLMITRIPTAN BIOGARAN	G	Zolmitriptan - 2.5mg	2.5mg	Tablet, orodispersible	1,683,835 L.L
J01FA10	ZOMAX	G	Azithromycin (dihydrate) - 200mg/5ml	200mg/5ml	Powder for suspension	258,018 L.L
J05AB01	ZOVIRAX	B	Aciclovir - 200mg/5ml	200mg/5ml	Suspension	487,815 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
L01XX44	ZALTRAP	BioTech	Aflibercept - 200mg/8ml	200mg/8ml	Injectable concentrate for solution	63,807,499 L.L
B01AF01	ZARLAN	G	Rivaroxaban - 20mg	20mg	Tablet, film coated	1,343,843 L.L
N06AB10	ZELAX 20	G	Escitalopram (oxalate) - 20mg	20mg	Caplet	1,544,075 L.L
C09AA03	ZESTRIL	B	Lisinopril (dihydrate) - 20mg	20mg	Tablet	636,981 L.L
C10AA01	ZOCOR	B	Simvastatin - 20mg	20mg	Tablet	976,526 L.L
D06AX01	ZETA	G	Fusidic acid - 20mg/g	20mg/g	Cream	178,731 L.L
L01EC01	ZELBORAF	B	Vemurafenib - 240mg	240mg	Tablet, film coated	142,041,587 L.L
L01EC01	ZELBORAF	B	Vemurafenib - 240mg	240mg	Tablet, film coated	L.L
C08DB01	ZALDEM CR	G	Diltiazem HCl - 240mg	240mg	Capsule, controlled release	1,002,123 L.L
J01FA10	ZITHROMAX	B	Azithromycin (dihydrate) - 250mg	250mg	Capsule	591,291 L.L
J01FA10	ZETRON	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
J01FA10	ZEVLEN	G	Azithromycin (dihydrate) - 250mg	250mg	Tablet, film coated	409,552 L.L
J01FA10	ZIMAX	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
J01FA10	ZOMAX	G	Azithromycin (dihydrate) - 250mg	250mg	Capsule	360,150 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 250mg	250mg	Tablet, film coated	349,399 L.L
J05AB01	ZOVIRAX IV	B	Aciclovir - 250mg	250mg	Injectable freeze dried substance	2,146,116 L.L
J01DC02	ZINNAT	B	Cefuroxime (axetil) - 250mg/5ml	250mg/5ml	Granules for suspension	1,120,782 L.L
A10BD07	ZERILUX	G	Sitagliptin - 25mg/ml	25mg/ml	Solution	1,172,179 L.L
L02AE03	ZOLADEX DEPOT	B	Goserelin (acetate) - 3.6mg	3.6mg	Injectable suspension	8,820,074 L.L
C09CA04	ZIOREL	G	Irbesartan - 300mg	300mg	Tablet, film coated	575,933 L.L
M04AA01	ZYLORIC	B	Allopurinol - 300mg	300mg	Tablet	302,365 L.L
J01FA10	ZITHROMAX	B	Azithromycin (dihydrate) - 300mg/7.5ml	300mg/7.5ml	Powder for suspension	489,159 L.L
L03AA02	ZARZIO	BioTech	Filgrastim - 300mcg/0.5ml	30MU/0.5ml	Injectable solution	13,053,190 L.L
L03AA02	ZARZIO	BioTech	Filgrastim - 300mcg/0.5ml	30MU/0.5ml	Injectable solution	13,053,190 L.L
P02CA03	ZENTEL	B	Albendazole - 400mg	400mg	Tablet	169,324 L.L